Disease | atrial fibrillation |
Comorbidity | C0034065|pulmonary embolism |
Sentences | 2 |
PubMedID- 23365716 | Rivaroxaban has successfully met primary efficacy and safety endpoints in large, randomized phase iii trials across several indications, including: prevention of venous thromboembolism in orthopedic patients undergoing elective hip or knee replacement surgery; treatment of deep vein thrombosis and secondary prevention of deep vein thrombosis and pulmonary embolism; stroke prevention in patients with atrial fibrillation; and secondary prevention of acute coronary syndrome. |
PubMedID- 22212132 | Is atrial fibrillation associated with pulmonary embolism. |
Page: 1